Shannon M, Dunlay, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14:591–602.

Article  Google Scholar 

Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, et al. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in obese older patients with heart failure with preserved ejection fraction: a Randomized Clinical Trial. JAMA. 2016;315:36–46.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Upadhya B, Amjad A, Stacey RB. Optimizing the management of obese HFpEF phenotype: can we mind both the Heart and the kidney? J Card Fail. 2020;26:108–11.

Article  PubMed  Google Scholar 

Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation. 2017;136:6–19.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Damman K, Valente MAE, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35:455–69.

Article  PubMed  Google Scholar 

Damman K, Perez AC, Anand IS, Komajda M, McKelvie RS, Zile MR, et al. Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment. J Am Coll Cardiol. 2014;64:1106–13.

Article  PubMed  CAS  Google Scholar 

Damman K, Solomon SD, Pfeffer MA, Swedberg K, Yusuf S, Young JB, et al. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme: WRF in HFREF and HFPEF. Eur J Heart Fail. 2016;18:1508–17.

Article  PubMed  CAS  Google Scholar 

Damman K, Testani JM. The kidney in heart failure: an update. Eur Heart J. 2015;36:1437–44.

Article  PubMed  PubMed Central  Google Scholar 

Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91:1224–35.

Article  PubMed  Google Scholar 

Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez-Jimenez F, et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;115:1428–34.

Article  PubMed  Google Scholar 

Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity Paradox in Heart failure. Prog Cardiovasc Dis. 2018;61:151–6.

Article  PubMed  Google Scholar 

Tsujimoto T, Kajio H. Abdominal obesity is Associated with an increased risk of all-cause mortality in patients with HFpEF. J Am Coll Cardiol. 2017;70:2739–49.

Article  PubMed  Google Scholar 

Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370:1383–92.

Article  PubMed  CAS  Google Scholar 

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive Summary. Crit Pathw Cardiol. 2005;4:198–203.

Article  PubMed  Google Scholar 

Desai AS, Lewis EF, Li R, Solomon SD, Assmann SF, Boineau R, et al. Rationale and design of the treatment of preserved cardiac function heart failure with an Aldosterone Antagonist Trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. Am Heart J. 2011;162:966–e97210.

Article  PubMed  CAS  Google Scholar 

Beldhuis IE, Myhre PL, Bristow M, Claggett B, Damman K, Fang JC, et al. Spironolactone in patients with heart failure, preserved ejection fraction, and worsening renal function. J Am Coll Cardiol. 2021;77:1211–21.

Article  PubMed  CAS  Google Scholar 

Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–72.

Article  PubMed  CAS  Google Scholar 

Valente MAE, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O’Connor CM, et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35:1284–93.

Article  PubMed  CAS  Google Scholar 

Beldhuis IE, Streng KW, Ter Maaten JM, Voors AA, van der Meer P, Rossignol P, et al. Renin–angiotensin system inhibition, worsening renal function, and Outcome in Heart failure patients with reduced and preserved ejection fraction: a Meta-analysis of published Study Data. Circ: Heart Fail. 2017;10:e003588.

Damman K, Tang WHW, Testani JM, McMurray JJV. Terminology and definition of changes renal function in heart failure. Eur Heart J. 2014;35:3413–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mulyadi L, Stevens C, Munro S, Lingard J, Bermingham M. Body fat distribution and total body fat as risk factors for microalbuminuria in the obese. Ann Nutr Metab. 2001;45:67–71.

Article  PubMed  CAS  Google Scholar 

Pinto-Sietsma S-J, Navis G, Janssen WMT, de Zeeuw D, Gans ROB, de Jong PE, et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003;41:733–41.

Article  PubMed  Google Scholar 

Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15:367–85.

Article  PubMed  PubMed Central  Google Scholar 

Koepp KE, Obokata M, Reddy YNV, Olson TP, Borlaug BA. Hemodynamic and functional impact of Epicardial Adipose tissue in heart failure with preserved ejection fraction. JACC: Heart Fail. 2020;8:657–66.

PubMed  Google Scholar 

Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128:951–68.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263–71.

Article  PubMed  Google Scholar 

Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010–3.

Article  PubMed  CAS  Google Scholar 

Jung UJ, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184–223.

Article  PubMed  PubMed Central  Google Scholar 

Pfeffer MA, Claggett B. Behind the scenes of TOPCAT — bending to inform. NEJM Evid. 2022. https://doi.org/10.1056/EVIDctcs2100007.

Article  PubMed  PubMed Central  Google Scholar 

Lemieux S, Prud’homme D, Bouchard C, Tremblay A, Després JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr. 1993;58:463–7.

Article  PubMed  CAS  Google Scholar 

Fu L, Zhou Y, Sun J, Zhu Z, Tai S. Abdominal obesity is Associated with an increased risk of all-cause mortality in males but not in females with HFpEF. Cardiovasc Ther. 2022;2022:1–11.

Article  Google Scholar 

Roriz AKC, Passos LCS, de Oliveira CC, Eickemberg M, Moreira P, de Sampaio A. Evaluation of the Accuracy of Anthropometric Clinical indicators of Visceral Fat in adults and Elderly. PLoS ONE. 2014;9:e103499.

Article  PubMed